Retension Pharmaceuticals Inc.
Support and Resistance Levels
Past performance
News About RTSN
All events for RTSN
All deals for RTSN
Financial Ratios
Financial Statements
RTSN vs Sector & Peers
About Retension Pharmaceuticals Inc.
Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling, a key mechanism underlying the development and severity of hypertension. The company was founded by Eric Keller and Paul Sweetnam in 2023 and is headquartered in Falls Church, VA. Website retensionpharmaceuticals.com
Headquarters Falls Church, VA, US